Company registration number 10627418 (England and Wales)
EMERALDS HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023
PAGES FOR FILING WITH REGISTRAR
EMERALDS HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
EMERALDS HEALTHCARE LIMITED
BALANCE SHEET
AS AT
28 FEBRUARY 2023
28 February 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
3
4,030
4,246
Current assets
Debtors
4
2,250
1,185
Cash at bank and in hand
14,425
23,930
16,675
25,115
Creditors: amounts falling due within one year
5
(19,883)
(17,629)
Net current (liabilities)/assets
(3,208)
7,486
Total assets less current liabilities
822
11,732
Provisions for liabilities
(750)
(807)
Net assets
72
10,925
Capital and reserves
Called up share capital
6
2
2
Profit and loss reserves
70
10,923
Total equity
72
10,925

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 26 October 2023 and are signed on its behalf by:
Dr E Emerald
Director
Company registration number 10627418 (England and Wales)
EMERALDS HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023
- 2 -
1
Accounting policies
Company information

Emeralds Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is 15 Pendle Drive, Calderstones Park, Whalley, Lancashire, BB7 9JT.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

The directors are not aware of any material uncertainties affecting the company and have therefore prepared the financial statements on a going concern basis.true

1.3
Turnover

Turnover is recognised at the fair value of the consideration receivable for services provided in the normal course of business.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
15% reducing balance
1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities are initially recognised at transaction cost. Financial liabilities classified as payable within one year are not amortised.

EMERALDS HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2023
1
Accounting policies
(Continued)
- 3 -
1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

 

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
2
2
EMERALDS HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2023
- 4 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 March 2022
7,545
Additions
475
At 28 February 2023
8,020
Depreciation and impairment
At 1 March 2022
3,299
Depreciation charged in the year
691
At 28 February 2023
3,990
Carrying amount
At 28 February 2023
4,030
At 28 February 2022
4,246
4
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
1,180
1,185
Other debtors
1,070
-
0
2,250
1,185
5
Creditors: amounts falling due within one year
2023
2022
£
£
Taxation and social security
-
0
1,077
Other creditors
19,883
16,552
19,883
17,629

Other creditors include £18,456 (2022 - £15,503) owed to the directors.

EMERALDS HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2023
- 5 -
6
Called up share capital
2023
2022
2023
2022
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A share of £1 each
1
1
1
1
Ordinary B share of £1 each
1
1
1
1
2
2
2
2
2023-02-282022-03-01false26 October 2023CCH SoftwareCCH Accounts Production 2023.200No description of principal activityDr E EmeraldMrs E G Ephraim106274182022-03-012023-02-28106274182023-02-28106274182022-02-2810627418core:OtherPropertyPlantEquipment2023-02-2810627418core:OtherPropertyPlantEquipment2022-02-2810627418core:CurrentFinancialInstrumentscore:WithinOneYear2023-02-2810627418core:CurrentFinancialInstrumentscore:WithinOneYear2022-02-2810627418core:CurrentFinancialInstruments2023-02-2810627418core:CurrentFinancialInstruments2022-02-2810627418core:ShareCapital2023-02-2810627418core:ShareCapital2022-02-2810627418core:RetainedEarningsAccumulatedLosses2023-02-2810627418core:RetainedEarningsAccumulatedLosses2022-02-2810627418core:ShareCapitalOrdinaryShares2023-02-2810627418core:ShareCapitalOrdinaryShares2022-02-2810627418bus:Director12022-03-012023-02-2810627418core:FurnitureFittings2022-03-012023-02-28106274182021-03-012022-02-2810627418core:OtherPropertyPlantEquipment2022-02-2810627418core:OtherPropertyPlantEquipment2022-03-012023-02-2810627418core:WithinOneYear2023-02-2810627418core:WithinOneYear2022-02-2810627418bus:PrivateLimitedCompanyLtd2022-03-012023-02-2810627418bus:SmallCompaniesRegimeForAccounts2022-03-012023-02-2810627418bus:FRS1022022-03-012023-02-2810627418bus:AuditExemptWithAccountantsReport2022-03-012023-02-2810627418bus:Director22022-03-012023-02-2810627418bus:FullAccounts2022-03-012023-02-28xbrli:purexbrli:sharesiso4217:GBP